the aid library

LIST OPTIONS

Filter

4156

Sort by:

Direction:

Download (140)

View PDF (154)

Health at a Glance: Europe 2020

OECD (2020) C1

State of Health in the EU Cycle. With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-open their economies to avoid further re-confinement... more

Download (128)

View PDF (167)

Colombia: Humanitarian needs overview 2019

OCHA OCHA (2019) C1

En los últimos cinco años y como parte del ciclo programático humanitario, se han identificado las personas con necesidades en Colombia (anual) en un esfuerzo conjunto de los socios del Equipo Humanitario de País, en coordinación con otras contrapartes del Estado. La afectación histórica de m... more

Download (368)

View PDF (956)

Climate change and Disaster Management

World Bank (2017) C1

- Pacific Possible Background Paper No.6

Download (872)

View PDF (801)

Plan Estrategico de la Respuesta Nacional a la Tuberculosis en Paraguay 2016-2020

Barrios, A.; A.C. Sarubbi; E. Quinonez de Meza; et al. Ministerio de Salud Publica y Bienestar Social; Programma nacional de Control de la Tuberculosis, Paraguay, et al. (2016) C_WHO

Download (832)

View PDF (723)

PLAN STRATEGIQUE DE LUTTE CONTRE LA TUBERCULOSE AU CAMEROUN 2015 - 2019

Ministère de la Santé Publique , PROGRAMME NATIONAL DE LUTTE CONTRE LA TUBERCULOSE (2014) C1

Download (1443)

View PDF (1038)

Cambodia Health System Review: The current policies and strategies of the health system’s governance, financing, and service delivery

Steve Peat SFU MPH Capstone Project (2013) CC

Download (333)

View PDF (658)

Nepal: SAARC Regional Strategy on TB/HIV Co-infection

SAARC Tuberculosis and HIVAIDS Centre Nepal (2011) C1

Download (827)

View PDF (1275)

What Works for Children in South Asia: Community Health Workers

UN Children's Fund UNICEF (2004) CC

Download (137)

View PDF (147)

HIV and universal health coverage

UNAIDS UNAIDS (2020) C2

A guide for civil society Accessed: 30.01.2020

Download (512)

View PDF (420)

National Strategic Plan Public Private Mix in Tuberculosis (2016-2020)

National TB Control Programme (NTP), DGHS, MoHFW (2016) C1

This 2016-2020 public-private mix strategic plan (PPM SP) is a 4-year framework designed to guide the National TB Control Programme (NTP) and its partners to implement PPM in Bangladesh. It provides goals, strategies and interventions for expanding and scaling up current PPM models and outlines appr... more

Download (948)

View PDF (2488)

An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights
recommended

TK Sundari Ravindran Asian-Pacific Resource & Research C0entre for Women (ARROW) (2015) C1

This guide was prepared to enable advocates to use data when advocating for universal access to SRHR at the national, regional and global levels. It is a direct outcome of the Strategic SRHR Indicators workshop held in Kuala Lumpur, Malaysia on 21-22 August for the project “Strengthening the N... more

Download (357)

View PDF (726)

At any price?

BUKO Pharma-Kampagne (2011) C1

Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India

Download (113)

View PDF (447)

Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review

Medina-Rincón, G.; Gallo-Bernal, S.; Jiménez, P.; et al. (2021) CC

Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493 .Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech... more

Download (94)

View PDF (477)

Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia

Cucunubá, Z.; Nouvellet, P.; Conteh, L. et al. BMJ Global Health (2022) CC

BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo... more

Download (105)

View PDF (700)

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data plat

Maguire, B.J.; Dahal, P.; Rashan, S. et al. PLOS Neglected Tropical Diseases (2021) CC

PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t... more

Download (168)

View PDF (320)

Vector-borne diseases: a handbook for pharmacists - Disease prevention, control, management and treatment

Gromek K., Hung M., Montero N. et al International Pharmaceutical Federation FIP (2020) C2

The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp... more

Download (41)

View PDF (36)

Multiple first-line therapies as part of the response to antimalarial drug resistance

World Health Organization WHO (2024) C_WHO

Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ... more

Download (36)

View PDF (30)

Policy statement and recommended actions for lowering sugar intake and reducing prevalence of type 2 diabetes and obesity in the Eastern Mediterranean Region

World Health Organization (WHO) World Health Organization (WHO) (2016) C_WHO

The documents focus on promoting healthier nutrition by addressing issues like sugar, salt, and fat intake, emphasizing their role in non-communicable diseases such as obesity, diabetes, and heart diseases. They include educational tools for children and adults to support balanced diets and public h... more

Download (45)

View PDF (43)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Download (39)

View PDF (39)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights recommended

An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights
recommended